NOVORON BIOSCIENCE
Novoron Bioscience develops novel therapeutic approaches for the treatment of disorders of the central nervous system. The company has made proprietary scientific discoveries in treatment of various pathologies of the central nervous system and is advancing a pipeline of biologic therapeutics for multiple sclerosis, spinal cord injury and glaucoma. Novoron is a Delaware C-corp headquartered in San Diego, California and is part of the JLABS innovation community.
NOVORON BIOSCIENCE
Industry:
Biotechnology Neuroscience Pharmaceutical
Founded:
2013-02-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.novoron.com
Total Employee:
1+
Status:
Active
Contact:
(858)324-5114
Email Addresses:
[email protected]
Total Funding:
4.27 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Content Delivery Network Organization Schema Google Apps For Business GoDaddy DNS YouTube Typekit
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
TARIS Biomedical
TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Novoron Bioscience
Two Bear Capital
Two Bear Capital investment in Seed Round - Novoron Bioscience
Backstage Capital
Backstage Capital investment in Seed Round - Novoron Bioscience
Official Site Inspections
http://www.novoron.com Semrush global rank: 4.15 M Semrush visits lastest month: 2.87 K
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Novoron Bioscience"
Novoron | Home
Novoron is pioneering drug development targeting low-density lipoprotein receptors, โฆSee details»
Novoron | Team
Novoron Bioscience's mission to develop therapies that reverse the debilitating consequences โฆSee details»
Novoron | Programs - Novoron Bioscience
Novoron has developed proprietary tools and unique expertise fundamental to exploiting LRP1 and related proteins for their maximal therapeutic potential while avoiding the potential pitfalls associated with off-target, or within-target โฆSee details»
Novoron Bioscience - Crunchbase Company Profile
Novoron Bioscience develops new therapeutic approaches to address neurological damage or disease in the central nervous system (CNS). Our โฆSee details»
Novoron Bioscience, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Novoron โฆSee details»
A. Taylor Bright - Co-Founder and Chief Operating Officer at โฆ
Finally, they became the Co-Founder and Chief Operating Officer of Novoron Bioscience in โฆSee details»
NOVORON BIOSCIENCE, INC. - VentureRadar
Dec 1, 2021ย ยท Website: http://www.novoron.com/ Develops novel therapeutic approaches for โฆSee details»
Two Bear Capital
Beyond the CNS, Novoronโs proprietary LRP-focused drug development platform will facilitate โฆSee details»
Novoron | Science & Pipeline
Learn more about Novoron Bioscience's first-in-class pipeline of therapeutics and the core technology that allows us to dissect and precisely target specific components of individual receptors in an unprecedented fashion.See details»
Travis Stiles - CEO & CSO at Novoron Bioscience | The Org
For more than a decade, Dr. Travis Stiles has exclusively studied the mechanisms underlying โฆSee details»
Novoron Bioscience - BIO International Convention 2024
Novoron Bioscience is pioneering drug development targeting low-density lipoprotein โฆSee details»
Novoron Bioscience - PitchBook
Operator of a biotechnology company intended to develop lipoprotein-receptor drugs to repair โฆSee details»
Novoron Bioscience Awarded NIH Grant for Research Into โฆ
SAN DIEGO, Jan. 28, 2022 /PRNewswire/ -- Novoron Bioscience, a San Diego -based โฆSee details»
Novoron Bioscience Raises $3M in Seed Financing from Two Bear โฆ
SAN DIEGO, Nov. 16, 2021 /PRNewswire/ -- Novoron Bioscience, a San Diego -based โฆSee details»
Novoron | News & Events
Novoron Bioscience, a San Diego-based biotechnology company developing first-in-class โฆSee details»
Novoron Bioscience - Overview, News & Similar companies
Novoron Bioscience contact info: Phone number: (858) 324-5114 Website: www.novoron.com โฆSee details»
NOVO 118 - AdisInsight - Springer
If your organization has a subscription, there are several access options, even while working โฆSee details»
Novoron Bioscience Welcomes Dr. David Weiner To The Executive โฆ
Oct 9, 2024ย ยท Novoron Bioscience is excited to announce that Dr. David Weiner is the newest โฆSee details»
Anyone can give me a summary of Heir of Novron? I can give
A war council is called and many of the surviving major characters are there. it is here that we โฆSee details»
Novoronโs History & Milestones
Sep 27, 2021ย ยท May 2016 - Xconomy identifies Novoron as a life sciences startup to watch. โฆSee details»